Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Oral Immunization of Chickens With Recombinant Lactobacillus plantarum Vaccine Against Early ALV-J Infection
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Oral Immunization of Chickens With Recombinant Lactobacillus plantarum Vaccine Against Early ALV-J Infection
Creator
Liu, Liu
Wang, Hongwei
Liu, Jianzhu
Geng, Na
Liu, Kangping
Liu, Yongxia
Qu, Yi
Shi, Mengke
Wang, Shenghua
Xu, Yuliang
Zhou, Dong
Gershwin, Laurel
Qu, Zhou
Xu, Shi
Source
PMC
abstract
In this study, a novel oral vaccine of recombinant Lactobacillus plantarum (L. plantarum) containing the gp85 protein was explored, and the effects of this vaccine on the prevention of subgroup J Avian Leukosis Virus (ALV-J) infection were assessed. In the current study, the gp85 protein of ALV-J was expressed on the surface of L. plantarum with the surface-display motif, pgsA, by constructing a shuttle vector pMG36e:pgsA:gp85. Surface localization of the fusion protein was verified by western blotting and flow cytometry. Subsequently, Specific Pathogen Free Hy-Line Brown layer chickens were orally vaccinated with the recombinant L. plantarum and presented with high levels of serum immunoglobulin G (IgG) and secretory immunoglobulin A (sIgA) titers in bile and duodenal-mucosal fluid. After challenged with ALV-J of a 3 × 10(3) 50% tissue culture infective dose (TCID50), serum samples of the chickens were collected and viremia was analyzed. Results showed that, compared to the L. plantarum and PBS control group, the recombinant L. plantarum group showed a significant rise in antibody levels after inoculation, and provide improved protection against ALV-J according to viremia detection. These results indicate that oral immunization with the recombinant L. plantarum provided an effective means for eliciting protective immune response against early ALV-J infection.
has issue date
2019-10-02
(
xsd:dateTime
)
bibo:doi
10.3389/fimmu.2019.02299
bibo:pmid
31632395
has license
cc-by
sha1sum (hex)
2835b0f9f06e3e829cfa7d3f1e3805af94249d65
schema:url
https://doi.org/10.3389/fimmu.2019.02299
resource representing a document's title
Oral Immunization of Chickens With Recombinant Lactobacillus plantarum Vaccine Against Early ALV-J Infection
has PubMed Central identifier
PMC6783503
has PubMed identifier
31632395
schema:publication
Front Immunol
resource representing a document's body
covid:2835b0f9f06e3e829cfa7d3f1e3805af94249d65#body_text
is
schema:about
of
named entity 'viremia'
named entity 'These'
named entity 'Virus'
named entity 'recombinant'
named entity 'antibody'
named entity 'presented'
named entity 'Vaccine'
named entity 'With'
named entity 'ACCORDING'
named entity 'GROUP'
named entity 'PREVENTION OF'
named entity 'HIGH'
named entity 'SHUTTLE VECTOR'
named entity 'WESTERN BLOTTING'
named entity 'LAYER'
named entity 'DISPLAY'
named entity 'COLLECTED'
named entity 'RISE'
named entity 'PROVIDE'
named entity 'CONSTRUCTING'
named entity 'THESE'
named entity 'EFFECTS'
named entity 'LEVELS'
named entity 'ELICITING'
named entity 'ORAL IMMUNIZATION'
named entity 'CHICKENS'
named entity 'TISSUE CULTURE'
named entity 'SUBGROUP'
named entity 'COMPARED'
named entity 'MUCOSAL'
named entity 'FUSION PROTEIN'
named entity 'SERUM'
named entity 'VERIFIED'
named entity 'CURRENT'
named entity 'EARLY'
named entity 'VACCINE'
named entity 'ANTIBODY'
named entity 'ORAL VACCINE'
named entity 'FREE'
named entity 'DETECTION'
named entity 'VACCINATED'
named entity 'MOTIF'
named entity 'INOCULATION'
named entity 'IMMUNE RESPONSE'
named entity 'PROTEIN '
named entity 'RECOMBINANT'
named entity '50%'
named entity 'INFECTIVE DOSE'
named entity 'CONTAINING'
named entity 'EFFECTIVE'
named entity 'SERUM IMMUNOGLOBULIN G'
named entity 'ORAL IMMUNIZATION'
named entity 'PRESENTED'
named entity 'IMPROVED'
named entity 'NOVEL'
named entity 'VIREMIA'
named entity 'SECRETORY IMMUNOGLOBULIN A'
named entity 'LINE'
named entity 'SAMPLES'
named entity 'STUDY'
named entity 'MEANS'
named entity 'LOCALIZATION'
named entity 'RECOMBINANT'
named entity 'INFECTION'
named entity 'VACCINE'
named entity 'FLUID'
named entity 'ORALLY'
named entity 'LACTOBACILLUS PLANTARUM'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 8
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software